Led Clinical Science Business Operations (functional excellence, processes, training, healthcare compliance, visual analytics, protocol and ICF development, patient insights) across four sites: South San Francisco, Welwyn (UK), Basel (Switzerland), and Shanghai. Reported directly to the four Senior Vice-Presidents of Clinical Development (Oncology and Hematology [PDO], Immunology, Infectious Diseases, and Ophthalmology [I2O], and Neuroscience [PDN]). • Managed leadership and development for the Global Development Leaders of ~40 molecule teams.• Ensured functional compliance and quality standards (including GCP/GVP, Sunshine Act, Disclosures, and SOPs) through training and knowledge oversight.• Developed Clinical Science training programs that allowed staff to learn core competencies. • Enabled medical data review using visual analytics for all early- and late-stage studies. • Managed protocol and ICF development across both early and late stage for all therapeutic areas, partnering with Clinical Operations, Biostatistics, and Safety Science.• Managed the budget and headcount for global Clinical Science across four sites to provide appropriate resourcing for clinical programs.

• Served as Chief of Staff to the Executive Vice President, Global Product Development, and CMO. Managed the Product Development leadership team, partnering with the Global Heads of Clinical Science, Biometrics, Safety, Regulatory, Project Management, Quality, and Clinical Operations. • Managed the activities of Clinical Science and six Clinical Development Heads (Oncology, Immunology, Virology, Metabolism, Neuroscience, and Ophthalmology). • Managed the budget reviews for Global Product Development and Clinical Science over five global sites (South San Francisco, Nutley, Basel, Welwyn, and Shanghai). • Implemented the Development Review Committee—technical review of all early- and late-stage development portfolio projects—globally across five sites. • Implemented cross-functional project team system for ~25 molecules, including creation of a global team leadership program.

Managed the strategic direction and operation of the Development Writing and Editing (Clinical and Nonclinical), Development eSubmissions, and Clinical Publications groups. Had overall accountability for the production, schedule, and publishing of all clinical and nonclinical documents and data for all Genentech regulatory submissions, e.g., protocols, clinical study reports, annual reports, INDs, BLAs/NDAs, supplements, and amendments. Managed writing and editing assistance for all clinical protocols and amendments, Investigator Brochures, CSRs, and other regulatory submissions as well as publications (manuscripts, posters, abstracts, and presentations) based on Genentech’s clinical trials. Managed technical reviews for all projects both pre- and post-IND and drafting formal recommendations in coordination with the executive members. Was accountable for the posting of all protocols and clinical trial results to clinicaltrials.gov.